'Immunomers' - Novel 3′-3′-linked CpG oligodeoxyribonucleotides as potent immunomodulatory agents

Nucleic Acids Research

Volumn 30, Issue 20, 2002, Pages 4460-4469

  Yu, Dong ^a   Kandimalla, Ekambar R ^a   Bhagat, Lakshmi ^a   Tang, Jin Yan ^a   Cong, Yanping ^a   Tang, Jimmy ^a   Agrawal, Sudhir ^a  

^a HYBRIDON INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DINUCLEOTIDE; DNA FRAGMENT; GLYCEROL DERIVATIVE; IMMUNOMODULATING AGENT; IMMUNOSTIMULATING AGENT; LIGAND; OLIGODEOXYRIBONUCLEOTIDE;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONJUGATION; CONTROLLED STUDY; CPG ISLAND; DRUG ACTIVITY; DRUG DESIGN; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; FEMALE; IMMUNE RESPONSE; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 0037109211     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/gkf582     Document Type: Article

References (55)

1. Tokunaga,T., Yamamoto,H., Shimada,S., Abe,H., Fukuda,T., Fujisawa,Y., Furutani,Y., Yano,O., Kataoka,T., Sudo,T., Makiguchi,N. and Suganuma,T. (1984) Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG.I. Isolation, physicochemical characterization, and antitumor activity. J. Natl Cancer Inst., 72, 955-962.
2. Messina,J.P., Gilkeson,G.S. and Pisetsky,D.S. (1991) Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA. J. Immunol., 147, 1759-1764.
3. Krieg,A.M., Yi,A.K., Matson,S., Waldschmidt,T.J., Bishop,G.A., Teasdale,R., Koretzky,G.A. and Klinman,D.M. (1995) CpG motifs in bacterial DNA trigger direct B-cell activation. Nature, 374, 546-549.
4. Sato,Y., Roman,M., Tighe,H., Lee,D., Corr,M., Nguyen,M.D., Silverman,G.J., Lotz,M., Carson,D.A. and Raz,E. (1996) Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science, 273, 352-354.
5. Yamamoto,S., Kuramoto,E., Shimada,S. and Tokunaga,T. (1988) In vitro augmentation of natural killer cell activity and production of interferon-α/β and -γ with deoxyribonucleic acid fraction from Mycobacterium bovis BCG. Jpn. J. Cancer Res., 79, 866-873.
6. Halpern,M.D., Kurlander,R.J. and Pisetsky,D.S. (1996) Bacterial DNA induces murine interferon-γ production by stimulation of interleukin-12 and tumor necrosis factor-α. Cell. Immunol., 167, 72-78.
7. Klinman,D.M., Yi,A.K., Beaucage,S.L., Conover,J. and Krieg,A.M. (1996) CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon-γ. Proc. Natl Acad. Sci. USA, 93, 2879-2883.
8. Zhao,Q., Temsamani,J., Zhou,R.Z. and Agrawal,S. (1997) Pattern and kinetics of cytokine production following administration of phosphorothioate oligonucleotides in mice. Antisense Nucleic Acid Drug Dev., 7, 495-502.
9. Yamamoto,S., Yamamoto,T., Kataoka,T., Kuramoto,E., Yano,O. and Tokunaga,T. (1992) Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN and augment IFN-mediated natural killer activity. J. Immunol., 148, 4072-4076.
10. Tokunaga,T., Yano,O., Kuramoto,E., Kimura,Y., Yamamoto,T., Kataoka,T. and Yamamoto,S. (1992) Synthetic oligonucleotides with particular base sequences from the cDNA encoding proteins of Mycobacterium bovis BCG induce interferons and activate natural killer cells. Microbiol. Immunol., 36, 55-66.
11. Liang,H., Nishioka,Y., Reich,C.F., Pisetsky,D.S. and Lipsky,P.E. (1996) Activation of human B cells by phosphorothioate oligodeoxynucleotides. J. Clin. Invest., 98, 1119-1129.
12. Gurunathan,S., Klinman,D.M. and Seder,R.A. (2000) DNA vaccines: immunology, application, and optimization. Annu. Rev. Immunol., 18, 927-974.
13. Krieg,A.M. (2002) CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol., 20, 709-760.
14. Agrawal,S. and Kandimalla,E.R. (2002) Medicinal chemistry and therapeutic potential of CpG DNA. Trends Mol. Med., 8, 114-121.
15. Hemmi,H., Takeuchi,O., Kawai,T., Kaisho,T., Sato,S., Sanjo,H., Matsumoto,M., Hoshino,K., Wagner,H., Takeda,K. and Akira,S. (2000) A Toll like receptor recognizes bacterial DNA. Nature, 408, 740-745.
16. Zhao,Q., Temsamani,J., Iadarola,P.L., Jiang,Z. and Agrawal,S. (1996) Effect of different chemically modified oligodeoxynucleotides on immune stimulation. Biochem. Pharmacol., 51, 173-182.
17. Kandimalla,E.R., Yu,D. and Agrawal,S. (2002) Towards optimal design of second-generation immunomodulatory oligonucleotides. Curr. Opin. Mol. Ther., 4, 122-129.
18. Zhao,Q., Yu,D. and Agrawal,S. (1999) Site of chemical modifications in CpG containing phosphorothioate oligodeoxynucleotide modulates its immunostimulatory activity. Bioorg. Med. Chem. Lett., 9, 3453-3458.
19. Zhao,Q., Yu,D. and Agrawal,S. (2000) Immunostimulatory activity of CpG containing phosphorothioate oligodeoxynucleotide is modulated by modification of a single deoxynucleoside. Bioorg. Med. Chem. Lett., 10, 1051-1054.
20. Yu,D., Kandimalla,E.R., Zhao,Q., Cong,Y. and Agrawal,S. (2002) Immunostimulatory properties of phosphorothioate CpG DNA containing both 3′-5′- and 2′-5′-internucleotide linkages. Nucleic Acids Res., 30, 1613-1619.
21. Yu,D., Kandimalla,E.R., Zhao,Q., Cong,Y. and Agrawal,S. (2001) Immunostimulatory activity of CpG oligonucleotides containing nonionic methylphosphonate linkages. Bioorg. Med. Chem., 9, 2803-2808.
22. Yu,D., Kandimalla,E.R., Zhao,Q., Cong,Y. and Agrawal,S. (2001) Modulation of immunostimulatory activity of CpG oligonucleotides by site-specific deletion of nucleobases. Bioorg. Med. Chem. Lett., 11, 2263-2267.
23. Kandimalla,E.R., Yu,D., Zhao,Q. and Agrawal,S. (2001) Effect of chemical modifications of cytosine and guanine in a CpG-motif of oligonucleotides: structure-immunostimulatory activity relationships. Bioorg. Med. Chem., 9, 807-813.
24. Yu,D., Zhao,Q., Kandimalla,E.R. and Agrawal,S. (2000) Accessible 5′-end of CpG-containing phosphorothioate oligodeoxynucleotides is essential for immunostimulatory activity. Bioorg. Med. Chem. Lett., 10, 2585-2588.
25. Kandimalla,E.R., Bhagat,L., Yu,D., Cong,Y., Tang,J. and Agrawal,S. (2002) Conjugation of ligands at the 5′-end of CpG DNA affects immunostimulatory activity. Bioconjug. Chem., 13, 966-974.
26. Kandimalla,E.R., Agrawal,S., Venkataraman,S. and Sasisekharan,V. (1995) Single strand targeted triplex formation: parallel-stranded DNA hairpin duplexes for targeting pyrimidine strands. J. Am. Chem. Soc., 117, 6416-6417.
27. Chaix,C., Iyer,R.P. and Agrawal,S. (1996) 3′-3′-Linked oligonucleotides synthesis and stability studies. Bioorg. Med. Chem. Lett., 6, 827-832.
28. Iyer,R.P., Egan,W., Regan,J.B. and Beaucage,S.L. (1990) 3H-1,2 benzodithiole-3 -one 1,1-dioxide as an improved sulfurizing reagent in the solid-phase synthesis of oligodeoxyribonucleoside phosphorothioates. J. Am. Chem. Soc., 112, 1253-1254.
29. Puglisi,J.D. and Tinoco,I.,Jr (1989) Absorbance melting curves of RNA. Methods Enzymol., 180, 304-325.
30. Branda,R.F., Moore,A.L., Mathews,L., McCormack,J.J. and Zon,G. (1993) Immune stimulation by an antisense oligomer complementrary to the rev gene of HIV-1. Biochem. Pharmacol., 45, 2037-2043.
31. Schreiber,E., Matthias,P., Muller,M.M. and Schaffner,W. (1989) Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res., 17, 6419-6420.
32. Bradford,M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
33. Stacey,K.J., Sweet,M.J. and Hume,D.A. (1996) Macrophages ingest and are activated by bacterial DNA. J. Immunol., 157, 2116-2122.
34. O'Hagan,D.T., MacKichan,M.L. and Singh,M. (2001) Recent developments in adjuvants for vaccines against infectious diseases. Biomol. Eng., 18, 69-85.
35. Leitner,W.W., Hammerl,P. and Thalhamer,J. (2001) Nucleic acid for the treatment of cancer: genetic vaccines and DNA adjuvants. Curr. Pharm. Des., 7, 1641-1667.
36. Spiegelberg,H.L. and Raz,E. (2002) DNA-based approaches to the treatment of allergies. Curr. Opin. Mol. Ther., 4, 64-71.
37. Kline,J.N. and Ballas,Z.K. (2002) DNA immunomodulation of asthma. Clin. Allergy Immunol., 16, 551-564.
38. Lewis,E.J., Agrawal,S., Bishop,J., Chadwick,J., Cristensen,N.D., Cuthill,S., Dunford,P., Field,A.K., Francis,J., Gibson,V., Greenham,A.K., Kelly,F., Kilkushie,R., Kreider,J.W., Mills,J.S., Mulqueen,M., Roberts,N.A., Roberts,P. and Szymkowski,D.E. (2000) Non-specific antiviral activity of antisense molecules targeted to the E1 region of human papillomavirus. Antiviral Res., 48, 187-196.
39. Masihi,K.N. (2001) Fighting infection using immunomodulatory agents. Expert Opin. Biol. Ther., 1, 641-653.
40. Warren,T.L. and Weiner,G.J. (2002) Synergism between cytosine-guanine oligodeoxynucleotides and monoclonal antibody in the treatment of lymphoma. Semin. Oncol., 29 (1 Suppl. 2), 93-97.
41. Hafner,M., Zawatzky,R., Hirtreiter,C., Buurman,W.A., Echtenacher,B., Hehlgans,T. and Mannel,D.N. (2002) Antimetastatic effect of CpG DNA mediated by type I IFN. Cancer Res., 61, 5523-5528.
42. Hartmann,G.,Weeratna,R.D., Ballas,Z.K., Payette,P., Blackwell,S., Suparto,I., Rasmussen,W.L., Waidschmidt,M., Sajuthi,D., Purcell,R.H., Davis,H.L. and Krieg,A.M. (2000) Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo. J. Immunol., 164, 1617-1624.
43. Chuang,T.H., Lee,J., Kline,L., Mathison,J.C. and Ulevitch,R.J. (2002) Toll-like receptor 9 mediates CpG-DNA signaling. J. Leukoc. Biol., 71, 538-544.
44. Wagner,H. (2002) Interactions between bacterial CpG-DNA and TLR9 bridge innate and adaptive immunity. Curr. Opin. Microbiol., 5, 62-69.
45. Temsamani,J., Roskey,A., Chaix,C. and Agrawal,S. (1997) In vivo metabolic profile of a phosphorothioate oligodeoxyribonucleotide. Antisense Nucleic Acid Drug Dev., 7, 159-165.
46. Temsamani,J., Kubert,M. and Agrawal, S. (1995) Sequence identity of the n-1 product of a synthetic oligonucleotide. Nucleic Acids Res., 23, 1841-1844.
47. Agrawal,S., Temsamani,J. and Tang,J.Y. (1991) Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice. Proc. Natl Acad. Sci. USA., 88, 7595-7599.
48. Temsamani,J., Tang,J.Y. and Agrawal,S. (1992) Capped oligodeoxynucleotide phosphorothioates. Pharmacokinetics and stability in mice. Ann. N. Y. Acad. Sci., 660, 318-320.
49. Temsamani,J., Tang,J.Y., Padmapriya,A., Kubert,M. and Agrawal,S. (1993) Pharmacokinetics, biodistribution, and stability of capped oligodeoxynucleotide phosphorothioates in mice. Antisense Res. Dev., 3, 277-284.
50. Levis,J.T. and Miller,P.S. (1994) Properties of exonuclease-resistant, psoralen- conjugated oligodeoxyribonucleotides in vitro and in cell culture. Antisense Res Dev., 4, 231-241.
51. Yu,D., Zhu,F.G., Bhagat,L.,Wang,H., Kandimalla,E.R., Zhang,R. and Agrawal,S. (2002) Potent CpG oligonucleotides containing phosphodiester linkages: in vitro and in vivo immunostimulatory properties. Biochem. Biophys. Res. Commun., 297, 83-90.
52. Pandolfi,D., Rauzi,F. and Capobianco,M.L. (1999) Evaluation of different types of end-capping modifications on the stability of oligonucleotides toward 3′- and 5′-exonucleases. Nucl. Nucl., 18, 2051-2069.
53. Iho,S., Yamamoto,T., Takahashi,T. and Yamamoto,S. (1999) Oligodeoxynucleotides containing palindrome sequences with internal 5′-CpG-3′ act directly on human NK and activated T cells to induce IFN-γ production in vitro. J. Immunol., 163, 3642-3652.
54. Krug,A., Rothenfusser,S., Hornung,V., Jahrsdorfer,B., Blackwell,S., Ballas,Z.K., Endres,S., Krieg,A.M. and Hartmann,G. (2001) Identification of CpG oligonucleotide sequences with high induction of IFN-α/β in plasmacytoid dendritic cells. Eur. J. Immunol., 31, 2154-2163.
55. Verthelyi,D., Ishii,K., Gursel,M., Takeshita,F. and Klinman,D.M. (2001) Human peripheral blood cells differentially recognize and respond to two distinct CpG motifs. J. Immunol., 166, 2372-2377.